BNF for Children 2021-2022: September 2021-22

Product Information

Elias-Jones, A.; Rylance, G. (2005). "The launch of the British National Formulary for Children". Archives of Disease in Childhood. 90 (10): 997–998. doi: 10.1136/adc.2005.080366. PMC 1720111. PMID 16177154. The British National Formulary is divided into various sections; with the main sections on drugs and preparations being organised by body system. Cefotaxime [update to dosing for uncomplicated gonorrhoea, and update to include dosing in children from 12 years old for disseminated gonococcal infection]. The BNF for Children developed from the British National Formulary (BNF), which prior to 2005 had provided information on the treatment of children, with the doses largely determined by calculations based on the body weight of the child.

Vaccines update: restructure of Influenza vaccine monograph—creation of monographs for influenza vaccine (live) and influenza vaccine (inactivated). Non-steroidal anti-inflammatory drugs: potential risks following prolonged use after 20 weeks of pregnancy [MHRA/CHM advice]. Aronson, J. K. (2004). "Drug interactions-information, education, and the British National Formulary". British Journal of Clinical Pharmacology. 57 (4): 371–372. doi: 10.1111/j.1365-2125.2004.02125.x. PMC 1884473. PMID 15025733. It is used by pharmacists and doctors (both general practitioners (GPs) and generalist hospital practitioners, and by other prescribing healthcare professionals (such as nurses, pharmacy technicians, paramedics, and dentists); as a reference for correct dosage, indication, interactions and side effects of drugs. It is also used as a reassurance by those administering drugs, for example a nurse on a hospital ward, and even for patients and others seeking an authoritative source of advice on any aspect of pharmacotherapy.VNRAS.com, BNF 73. "BNF 73" (PDF). Archived (PDF) from the original on 21 October 2021. {{ cite web}}: CS1 maint: numeric names: authors list ( link) Vaccines update [classifications changed to Vaccines, live or Vaccines, inactivated and non-replicating].

COVID-19 vaccine: update to Pfizer/BioNTech vaccine ( Comirnaty®) to include use in children from 6 months old. Azithromycin [update to dosing for uncomplicated non-gonococcal urethritis in children aged 12 to 17 years old]. VNRAS.com. "BNF for Children BNFC 2019-2020" (PDF). Archived from the original (PDF) on 11 October 2021 . Retrieved 1 May 2022. Ciprofloxacin [update to include dosing in children from 12 years old for uncomplicated gonorrhoea and disseminated gonococcal infection].Wade, O. L. (1993). "British National Formulary: Its birth, death, and rebirth". BMJ (Clinical Research Ed.). 306 (6884): 1051–1054. doi: 10.1136/bmj.306.6884.1051. PMC 1676980. PMID 8490505. Methotrexate: advise patients to take precautions in the sun to avoid photosensitivity reactions [MHRA/CHM advice].

BNF - NHS Evidence - Search Engine for Evidence in Health and Social Care". Archived from the original on 1 October 2012 . Retrieved 2012-06-14. British National Formulary for Children - editorial staff". BNFC. NICE . Retrieved 21 January 2021. Information on drugs is drawn from the manufacturers' product literature, medical and pharmaceutical literature, regulatory authorities and professional bodies. Advice is constructed from clinical literature, and reflects, as far as possible, an evaluation of the evidence from diverse sources. The BNF also takes account of authoritative national guidelines and emerging safety concerns. In addition, the Joint Formulary Committee takes advice on all therapeutic areas from advisers from expert groups; this ensures that the BNF's recommendations are relevant to practice. In September 2016, the National Institute for Health and Care Excellence (NICE) in the UK gave NICE accreditation to the processes to produce BNF publications; a further review in 2021 resulted in the successful renewal of accreditation. [3] History [ edit ] Vaccines update: restructure of Typhoid vaccine monograph—creation of monographs for typhoid vaccine (live) and typhoid vaccine (inactivated).

Drugs that cause hepatotoxicity, drugs with CNS depressant effects, and drugs that increase serum potassium: pharmacodynamic effects drug groups revalidated and updated; see Appendix 1 interactions. Digital Medicines Information Suite". Archived from the original on 19 December 2008 . Retrieved 22 December 2008. MedicinesComplete Many individuals and organisations contribute towards the preparation of the BNF. It is authored by Pharmaceutical Press, the Royal Pharmaceutical Society's (RPS) knowledge business; and is jointly published by the BMJ (owned by the BMA), and Pharmaceutical Press (owned by the RPS). It is published under the authority of a Joint Formulary Committee (JFC), [2] which comprises pharmacy, medical, nursing, and lay representatives; there are also representatives from the Medicines and Healthcare products Regulatory Agency (MHRA), the UK Health Departments, and a national guideline producer. Drugs that cause thromboembolism: pharmacodynamic effects drug group deleted from Appendix 1 interactions.